I.Ceram announced on Wednesday that it had secured new financing to help bring its antibiotic-loaded implants to market.

The specialist in innovative biocompatible ceramic implants says the package includes the issue, for up to one million euros, of bonds convertible into new shares or to be issued with warrants to Alpha Blue Ocean.

The group will also benefit from a 400.000 subsidy from the public investment bank Bpifrance as part of the 'I.Nov' project.

In a press release, I.Ceram explains that 'classic' financing by means of a capital increase or loan is impossible at the present time for a company focused on innovation.

The company also points out that the design of an implantable medical device is currently approaching that of a drug, with the new European regulatory environment imposing 'extremely costly' pre-clinical and clinical studies.

Copyright (c) 2024 CercleFinance.com. All rights reserved.